{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:genetic:nf1-vasculopathy",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T12:56:56.000Z",
    "contributors": [
      "copilot"
    ],
    "status": "enhanced",
    "reviewedBy": [],
    "confidence": 0.9,
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-connective-tissue",
    "type": "genetic-syndrome",
    "difficulty": "advanced",
    "importance": "high",
    "isNativeDomain": true
  },
  "content": {
    "title": "Neurofibromatosis Type 1 Vasculopathy (NF1)",
    "description": "Vascular complications of neurofibromatosis type 1, including arterial stenosis, aneurysms, and arteriovenous malformations affecting various vascular beds.",
    "definition": "NF1 vasculopathy refers to the spectrum of vascular abnormalities occurring in patients with NF1 (mutation in NF1 gene encoding neurofibromin). Manifestations include renal artery stenosis causing hypertension, cerebrovascular moyamoya-like changes, aneurysms, and vessel wall fragility complicating surgical intervention.",
    "clinical_features": {
      "genetic_basis": [
        "Mutation in NF1 gene on chromosome 17q11.2",
        "Encodes neurofibromin (tumor suppressor)",
        "Autosomal dominant inheritance",
        "Vascular smooth muscle affected"
      ],
      "vascular_manifestations": [
        "Renal artery stenosis (most common vascular issue)",
        "Moyamoya-like cerebrovascular disease",
        "Aneurysms (aortic, visceral, intracranial)",
        "Arteriovenous malformations",
        "Coarctation-like aortic narrowing"
      ],
      "clinical_implications": [
        "Renovascular hypertension - often refractory",
        "Stroke risk from cerebrovascular involvement",
        "Aneurysm rupture risk",
        "Vessel fragility complicates surgery",
        "Higher endovascular complication rates"
      ],
      "surveillance_recommendations": [
        "Blood pressure monitoring at all visits",
        "Consider renal artery imaging if hypertensive",
        "Brain MRI/MRA if neurologic symptoms",
        "Careful preoperative vascular assessment"
      ]
    },
    "codes": {
      "snomed_ct": [
        "19133005"
      ],
      "icd_10": [
        "Q85.01"
      ]
    },
    "relationships": {
      "skos:broader": [
        "vascular:genetic-syndromes"
      ],
      "skos:related": [
        "vascular:renovascular-htn",
        "vascular:fmd"
      ],
      "skos:narrower": []
    },
    "cross_domain_references": [
      {
        "target": "neurology:moyamoya",
        "relationship": "associated_with",
        "description": "Moyamoya-like cerebrovascular changes in NF1"
      }
    ],
    "pedagogy": {
      "learning_objectives": [
        "Identify NF1 vascular manifestations",
        "Recognize renal artery stenosis as common finding",
        "Understand surgical implications of vasculopathy",
        "Apply appropriate surveillance"
      ],
      "clinical_pearls": [
        "Renal artery stenosis is most common vascular manifestation",
        "May mimic fibromuscular dysplasia angiographically",
        "Vessel fragility makes angioplasty and surgery challenging",
        "Moyamoya in NF1 has high stroke risk",
        "Always assess BP in NF1 patients - renovascular HTN common"
      ],
      "board_yield": "MEDIUM"
    },
    "statement": "Neurofibromatosis Type 1 Vasculopathy (NF1) is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Genetic-Connective-Tissue that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Neurofibromatosis Type 1 Vasculopathy (NF1) helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Neurofibromatosis Type 1 Vasculopathy (NF1) include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Neurofibromatosis Type 1 Vasculopathy (NF1)."
    }
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Neurofibromatosis Type 1 Vasculopathy (NF1). Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}